(Q63317168)
Statements
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease (English)
0 references
9 August 2012
0 references
3 November 2016
0 references
23
0 references
18 year
0 references
80 year
0 references